FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1475-1477 November 12, 1998 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Cosset, J.M. Related Article by Miller, T. P.

To the Editor: Miller et al. (July 2 issue)¹ are to be commended on their report of the randomized trial comparing full-dose chemotherapy with limited chemotherapy and involved-field radiation for the treatment of localized intermediate-grade and high-grade non-Hodgkin's lymphoma. Previously, the management of this condition with chemotherapy and radiotherapy has been based on retrospective reports and small phase 2 studies and has been the subject of some controversy.²

Miller et al. demonstrated that three cycles of chemotherapy followed by involved-field radiotherapy, as compared with eight cycles of chemotherapy alone, resulted in an improvement of 10 percentage points in the estimated . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.